SARMs & Androgen Modulators
Selective Androgen Receptor Modulators (SARMs) and related compounds. Included for educational comparison with peptide therapies.
3 peptides in this category
Ostarine (MK-2866)
Ostarine (MK-2866, Enobosarm) is one of the most extensively studied Selective Androgen Receptor Modulators (SARMs). Developed by GTx Inc. (now Onconova) and Me...
Phase II and Phase III clinical trials completed for cancer cachexia and stressRAD-140 (Testolone)
RAD-140 (Testolone) is a potent, orally bioavailable nonsteroidal SARM developed by Radius Health. It demonstrates one of the highest anabolic-to-androgenic rat...
Phase I clinical trials ongoing for breast cancer. Preclinical data in primatesCardarine (GW-501516)
Cardarine (GW-501516) is a PPARδ (peroxisome proliferator-activated receptor delta) agonist, not a SARM in the strict sense, but it is commonly grouped with SAR...
Clinical development discontinued by GSK in 2007 due to carcinogenicity in roden